Inspire Medical Systems, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Inspire Medical Systems, Inc. (INSP), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are INSP insiders buying or selling?
In the last 12 months, Inspire Medical Systems, Inc. insiders reported 0 open-market purchases ($0) and 8 sales ($665.8K) — net selling of $665.8K. Since May 2018, Trabud has recorded 198 Form 4 filings for INSP: 13 buys ($18.5M) and 185 sells ($818.2M).
Source: SEC EDGAR Form 4
What stands out
- No Inspire Medical Systems, Inc. insider made an open-market purchase in the last 12 months; the 8 reported open-market sales totaled $665.8K.
Key Statistics (May 2018 – Aug 11, 2026)
Total Form 4 filings
198
SEC EDGAR
Insider filers
20
Insider buys (13)
$18.5M
Insider sells (185)
$818.2M
Insider sentiment
Net sellingNet insider flow of $799.7M in net selling since May 2018, and $665.8K in net selling over the last 12 months.
Recent INSP insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Jason P Kelly | Title - Chief Manufacturing and Quality Officer. | Sale | 963 | $59.55 | $57.3K | SEC ↗ |
| May 19, 2026 | John Rondoni | Title: Chief Product and Innovation Officer. | Sale | 2.6K | $43.28 | $114.3K | SEC ↗ |
| May 15, 2026 | John Rondoni | Title: Chief Product and Innovation Officer. | Sale | 700 | $43.01 | $30.1K | SEC ↗ |
| May 11, 2026 | Shawn Mccormick | Director | Sale | 696 | $45.31 | $31.5K | SEC ↗ |
| Jan 12, 2026 | John Rondoni | Title: Chief Product and Innovation Officer. All sale transactions reported herein were made pursuan | Sale | 109 | $100.00 | $10.9K | SEC ↗ |
| Dec 4, 2025 | Shawn Mccormick | Director | Sale | 1.2K | $139.00 | $166.8K | SEC ↗ |
| Dec 1, 2025 | Shawn Mccormick | Director | Sale | 2.0K | $127.48 | $255.0K | SEC ↗ |
| Nov 25, 2025 | Curet Myriam | Director | Sale | 1 | — | -$188.07 | SEC ↗ |
| Sep 3, 2025 | Richard Buchholz | Chief Financial Officer | Sale | 11.0K | $93.39 | $1.0M | SEC ↗ |
| May 21, 2025 | John Rondoni | Chief Product and Innovation Officer | Sale | 1.7K | $149.38 | $259.0K | SEC ↗ |
| May 5, 2025 | Shawn Mccormick | Director | Sale | 360 | $160.00 | $57.6K | SEC ↗ |
| Mar 5, 2025 | Randy Ban | Executive Vice President, Patient Access and Therapy Development. All transactions reported herein w | Sale | 3.9K | $185.84 | $733.5K | SEC ↗ |
| Mar 5, 2025 | John Rondoni | Chief Technology Officer | Sale | 2.3K | $185.60 | $424.5K | SEC ↗ |
| Feb 18, 2025 | Randy Ban | Executive Vice President, Patient Access and Therapy Development | Sale | 25.6K | $183.50 | $4.7M | SEC ↗ |
| Feb 14, 2025 | John Rondoni | Chief Technology Officer | Sale | 583 | $170.49 | $99.4K | SEC ↗ |
| Jan 10, 2025 | John Rondoni | Chief Technology Officer | Sale | 58 | $215.00 | $12.5K | SEC ↗ |
| Nov 5, 2024 | John Rondoni | Chief Technology Officer | Sale | 8.7K | $193.47 | $1.7M | SEC ↗ |
| Sep 11, 2024 | Shawn Mccormick | Director | Sale | 800 | $220.00 | $176.0K | SEC ↗ |
| Sep 11, 2024 | John Rondoni | Chief Technology Officer | Sale | 31 | $215.00 | $6.7K | SEC ↗ |
| Aug 23, 2024 | John Rondoni | Chief Technology Officer | Sale | 5.0K | $189.83 | $949.1K | SEC ↗ |
| Aug 20, 2024 | Randy Ban | Chief Commercial Officer | Sale | 21.0K | $192.05 | $4.0M | SEC ↗ |
| Apr 18, 2024 | Richard Buchholz | Chief Financial Officer | Sale | 15.0K | $230.03 | $3.5M | SEC ↗ |
| Apr 4, 2024 | Timothy P. Herbert | CEO and President | Sale | 40.0K | $205.09 | $8.2M | SEC ↗ |
| Apr 3, 2024 | Jerry C Griffin | Director | Sale | 32 | $213.99 | $6.8K | SEC ↗ |
| Mar 27, 2024 | Jerry C Griffin | Director | Sale | 554 | $197.81 | $109.6K | SEC ↗ |
Showing the 25 most recent of 198 Form 4 filings for Inspire Medical Systems, Inc..
Most active INSP insiders
- Timothy P. Herbert29 filings
- Randy Ban25 filings
- Jerry C Griffin24 filings
- Richard Buchholz20 filings
- John Rondoni15 filings
Ask anything about INSP insider activity
Use Trabud's AI agent to query Inspire Medical Systems, Inc.'s Form 4 history in plain English — "Show me INSP CEO purchases this year" or compare it against any other ticker.
Open the AI agentINSP insider trading FAQ
Are Inspire Medical Systems, Inc. insiders buying or selling?
In the last 12 months, Inspire Medical Systems, Inc. insiders reported 0 open-market purchases ($0) and 8 sales ($665.8K) — net selling of $665.8K. Since May 2018, Trabud has recorded 198 Form 4 filings for INSP: 13 buys ($18.5M) and 185 sells ($818.2M). Over the full record that is net selling of $799.7M.
How many insiders trade INSP stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Inspire Medical Systems, Inc.. The most recent filing was accepted on Aug 11, 2026.
Where does Trabud get INSP insider trading data?
All INSP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.